ABSTRACT
Over many years, therapeutic protein manufacturers have addressed the issue of product immunogenicity focusing on the active pharmaceutical ingredient. Recently, concerns about immune responses to contaminating host cell proteins (HCPs) have emerged, mainly due to concerns about their contribution to anti-drug immune responses and drug safety. The presence of Chinese hamster ovary (CHO) -derived HCPs contributed to the cancellation of two clinical trials in 2012. CHO cells are the most commonly used mammalian cell expression systems in recombinant protein production. The publication of the widely-used CHO-K1 genome and transcriptome provides an opportunity to analyze CHO HCPs and better understand their potential to drive immune responses. Of greatest concern are immune responses that may be cross-reactive with human T cell epitopes. We analyzed CHO-derived protein sequences from three overlapping datasets. These datasets consisted of (1) expressed; (2) putatively secreted; and (3) experimentally determined CHO HCPs. After arriving at a final subset of 1757 constitutively expressed CHO proteins, we used our T cell epitope prediction tool, EpiMatrix, to explore CHO HCP immunogenicity as defined by their relative epitope abundance. Each protein received an immunogenicity score reflecting T cell epitope content, and the results revealed 26% of the 1757 proteins analyzed were above a pre-defined threshold for potential immunogenicity, containing an abundance of predicted T cell epitopes. A subset of these proteins was then evaluated for epitopes that were substantially different from the human genome. This is the first step in the important process of uncovering the potential for HCPs to contribute to unwanted immunogenicity.
- Walsh, G. Biopharmaceutical benchmarks. Nat Biotechnol, 18, 8 (Aug 2000), 831--833.Google ScholarCross Ref
- Jayapal, K., Wlaschin, K., Hu, W. and Yap, M. Recombinant protein therapeutics from CHO cells - 20 years and counting. Chemical Engineering Progress, 103, 2007), 40--47.Google Scholar
- Higgins, E. Carbohydrate analysis throughout the development of a protein therapeutic. Glycoconj J, 27, 2 (Feb 2010), 211--225. DOI= http://dx.doi.org/10.1007/s10719-009-9261-xGoogle ScholarCross Ref
- Omasa, T., Onitsuka, M. and Kim, W. D. Cell engineering and cultivation of chinese hamster ovary (CHO) cells. Curr Pharm Biotechnol, 11, 3 (Apr 2010), 233--240.Google ScholarCross Ref
- Champion, K., Madden, H., Dougherty, J. and Shacter, E. Defining Your Product Profile and Maintaining Control Over It. BioProcess International, 3, 8 2005), 52--57.Google Scholar
- European Medicines Agency. ICH Topic Q 6 B. Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. 1999.Google Scholar
- FDA Draft Guidance for Industry Quality Considerations in Demonstrating Biosimilarity to a Reference Protein Product. 2012.Google Scholar
- Hai, S.-H., McMurry, J. A., Knopf, P. M., Martin, W. and De Groot, A. S. Immunogenicity Screening Using in Silico Methods: Correlation between T-Cell Epitope Content and Clinical Immunogenicity of Monoclonal Antibodies. John Wiley & Sons, Inc. 2009. DOI= http://dx.doi.org/10.1002/9780470485408.ch18Google Scholar
- De Groot, A. S. and Martin, W. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol, 131, 2 (May 2009), 189--201. DOI= http://dx.doi.org/10.1016/j.clim.2009.01.009Google ScholarCross Ref
- Vider-Shalit, T., Sarid, R., Maman, K., Tsaban, L., Levi, R. and Louzoun, Y. Viruses selectively mutate their CD8+ T-cell epitopes--a large-scale immunomic analysis. Bioinformatics, 25, 12 (Jun 15 2009), i39-44. DOI= http://dx.doi.org/10.1093/bioinformatics/btp221 Google ScholarDigital Library
- Louzoun, Y., Vider, T. and Weigert, M. T-cell epitope repertoire as predicted from human and viral genomes. Mol Immunol, 43, 6 (Feb 2006), 559--569.Google ScholarCross Ref
- Koren, E., De Groot, A. S., Jawa, V., Beck, K. D., Boone, T., Rivera, D., Li, L., Mytych, D., Koscec, M., Weeraratne, D., Swanson, S. and Martin, W. Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein. Clin Immunol, 124, 1 (Jul 2007), 26--32. DOI= http://dx.doi.org/10.1016/j.clim.2007.03.544Google ScholarCross Ref
- Tatarewicz, S. M., Wei, X., Gupta, S., Masterman, D., Swanson, S. J. and Moxness, M. S. Development of a maturing T-cell-mediated immune response in patients with idiopathic Parkinson's disease receiving r-metHuGDNF via continuous intraputaminal infusion. J Clin Immunol, 27, 6 (Nov 2007), 620--627. DOI= http://dx.doi.org/10.1007/s10875-007-9117-8Google ScholarCross Ref
- De Groot, A. S., Jesdale, B. M., Szu, E., Schafer, J. R., Chicz, R. M. and Deocampo, G. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. AIDS Res Hum Retroviruses, 13, 7 (May 1 1997), 529--531.Google ScholarCross Ref
- Bond, K. B., Sriwanthana, B., Hodge, T. W., De Groot, A. S., Mastro, T. D., Young, N. L., Promadej, N., Altman, J. D., Limpakarnjanarat, K. and McNicholl, J. M. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais. AIDS Res Hum Retroviruses, 17, 8 (May 20 2001), 703--717.Google ScholarCross Ref
- McMurry, J., Sbai, H., Gennaro, M. L., Carter, E. J., Martin, W. and De Groot, A. S. Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes. Tuberculosis (Edinb), 85, 1-2 (Jan-Mar 2005), 95--105. DOI= http://dx.doi.org/10.1016/j.tube.2004.09.005Google ScholarCross Ref
- Dong, Y., Demaria, S., Sun, X., Santori, F. R., Jesdale, B. M., De Groot, A. S., Rom, W. N. and Bushkin, Y. HLA-A2-restricted CD8+-cytotoxic-T-cell responses to novel epitopes in Mycobacterium tuberculosis superoxide dismutase, alanine dehydrogenase, and glutamine synthetase. Infect Immun, 72, 4 (Apr 2004), 2412--2415.Google ScholarCross Ref
- Koita, O. A., Dabitao, D., Mahamadou, I., Tall, M., Dao, S., Tounkara, A., Guiteye, H., Noumsi, C., Thiero, O., Kone, M., Rivera, D., McMurry, J. A., Martin, W. and De Groot, A. S. Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island. Hum Vaccin, 2, 3 (May-Jun 2006), 119--128.Google Scholar
- Ardito, M., De Groot, A., McMurry, J. A., Moise, L., Yang, W. and Martin, W. EpiMatrix: Tool for Accelerated Epitope Selection and Vaccine Design. 2008.Google Scholar
- Jin, M., Szapiel, N., Zhang, J., Hickey, J. and Ghose, S. Profiling of host cell proteins by two-dimensional difference gel electrophoresis (2D-DIGE): Implications for downstream process development. Biotechnol Bioeng, 105, 2 (Feb 1 2010), 306--316. DOI= http://dx.doi.org/10.1002/bit.22532Google ScholarCross Ref
- Doneanu, C. E., Xenopoulos, A., Fadgen, K., Murphy, J., Skilton, S. J., Prentice, H., Stapels, M. and Chen, W. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry. MAbs, 4, 1 (Jan-Feb 2011), 24--44.Google Scholar
- Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., Andersen, M. R., Neff, N., Passarelli, B., Koh, W., Fan, H. C., Wang, J., Gui, Y., Lee, K. H., Betenbaugh, M. J., Quake, S. R., Famili, I. and Palsson, B. O. The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line. Nat Biotechnol, 29, 8 (Aug 2011), 735--741. DOI= http://dx.doi.org/10.1038/nbt.1932Google ScholarCross Ref
- Becker, J., Hackl, M., Rupp, O., Jakobi, T., Schneider, J., Szczepanowski, R., Bekel, T., Borth, N., Goesmann, A., Grillari, J., Kaltschmidt, C., Noll, T., Puhler, A., Tauch, A. and Brinkrolf, K. Unraveling the Chinese hamster ovary cell line transcriptome by next-generation sequencing. J Biotechnol, 156, 3 (Dec 10 2011), 227--235.Google ScholarCross Ref
- Sprenger, J., Lynn Fink, J., Karunaratne, S., Hanson, K., Hamilton, N. A. and Teasdale, R. D. LOCATE: a mammalian protein subcellular localization database. Nucleic Acids Res, 36, Database issue (Jan 2008), D230--233.Google Scholar
- Rost, B. Twilight zone of protein sequence alignments. Protein Eng, 12, 2 (Feb 1999), 85--94.Google ScholarCross Ref
- Petersen, T. N., Brunak, S., von Heijne, G. and Nielsen, H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods, 8, 10 2011), 785--786. DOI= http://dx.doi.org/10.1038/nmeth.1701Google Scholar
- Southwood, S., Sidney, J., Kondo, A., del Guercio, M. F., Appella, E., Hoffman, S., Kubo, R. T., Chesnut, R. W., Grey, H. M. and Sette, A. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol, 160, 7 (Apr 1 1998), 3363--3373.Google Scholar
- McMurry, J. A., Gregory, S. H., Moise, L., Rivera, D., Buus, S. and De Groot, A. S. Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine. Vaccine, 25, 16 (Apr 20 2007), 3179--3191.Google ScholarCross Ref
- Moise, L., Buller, R. M., Schriewer, J., Lee, J., Frey, S. E., Weiner, D. B., Martin, W. and De Groot, A. S. VennVax, a DNA-prime, peptide-boost multi-T-cell epitope poxvirus vaccine, induces protective immunity against vaccinia infection by T cell response alone. Vaccine, 29, 3 (Jan 10 2011), 501--511.Google ScholarCross Ref
- Moss, S. F., Moise, L., Lee, D. S., Kim, W., Zhang, S., Lee, J., Rogers, A. B., Martin, W. and De Groot, A. S. HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine, 29, 11 (Mar 3 2011), 2085--2091. DOI= http://dx.doi.org/10.1016/j.vaccine.2010.12.130Google ScholarCross Ref
- Diamond, B. Speculations on the immunogenicity of self proteins. Dev Biol (Basel), 1122003), 29--34.Google Scholar
- De Groot, A. S., Goldberg, M., Moise, L. and Martin, W. Evolutionary deimmunization: an ancillary mechanism for self-tolerance? Cell Immunol, 244, 2 (Dec 2006), 148--153. DOI= http://dx.doi.org/10.1016/j.cellimm.2007.02.006Google ScholarCross Ref
- Moise, L., Song, C., Martin, W. D., Tassone, R., De Groot, A. S. and Scott, D. W. Effect of HLA DR epitope deimmunization of Factor VIII in vitro and in vivo. Clin Immunol, 142, 3 (Mar 2012), 320--331.Google ScholarCross Ref
- Inaba, H., Pan, D., Shin, Y. H., Martin, W., Buchman, G. and De Groot, L. J. Immune response of mice transgenic for human histocompatibility leukocyte Antigen-DR to human thyrotropin receptor-extracellular domain. Thyroid, 19, 11 (Nov 2009), 1271--1280.Google ScholarCross Ref
- Koren, E., Zuckerman, L. A. and Mire-Sluis, A. R. Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction. Curr Pharm Biotechnol, 3, 4 (Dec 2002), 349--360.Google ScholarCross Ref
- Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J. J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., Varet, B. and Mayeux, P. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med, 346, 7 (Feb 14 2002), 469--475.Google ScholarCross Ref
- Prasad, S., Kohm, A. P., McMahon, J. S., Luo, X. and Miller, S. D. Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9-23 epitope and involves functional epitope spreading. J Autoimmun (May 28 2012).Google Scholar
- Grosenbaugh, D. A., Leard, A. T., Bergman, P. J., Klein, M. K., Meleo, K., Susaneck, S., Hess, P. R., Jankowski, M. K., Jones, P. D., Leibman, N. F., Johnson, M. H., Kurzman, I. D. and Wolchok, J. D. Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor. Am J Vet Res, 72, 12 (Dec 2011), 1631--1638.Google ScholarCross Ref
- De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W. and Martin, W. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood, 112, 8 (Oct 15 2008), 3303--3311. DOI= http://dx.doi.org/10.1182/blood-2008-02-138073Google ScholarCross Ref
Index Terms
- Immunoinformatic analysis of Chinese hamster ovary (CHO) protein contaminants in therapeutic protein formulations
Recommendations
Immunoinformatic discovery of potential cross-reactive T cell epitopes in the measles genome
BCB '11: Proceedings of the 2nd ACM Conference on Bioinformatics, Computational Biology and BiomedicineT cells are key mediators of inflammatory processes that can be activated by pathogens and vaccines. Some vaccine antigens may encode T cell epitopes that can cross-react with either human or human microbiome epitopes, causing deviation of the T cell ...
Epitopes based drug design for dengue virus envelope protein
Display Omitted A conserved region QHGTI in B and T cell epitopes of dengue envelope glycoprotein was predicted.A reverse pharmacophore mapping approach was used to develop phamacophore model.ChemBridge database of compounds was screen on the basis of ...
High-specificity targets in SARS-CoV-2 N protein for serological detection and distinction from SARS-CoV
AbstractNumerous serological detection kits are being rapidly developed and approved for screening and diagnosing suspected coronavirus disease 2019 (COVID-19) cases. However, cross-reactivity between pre-existing antibodies against other ...
Highlights- Strong cross-reactivity between SARS-CoV-2 and SARS-CoV N protein serological detection.
Comments